SLC25A20 and carnitine-acylcarnitine translocase deficiency: Four patients (4/32, 12.5%) had metabolic abnormalities, including methylmalonicacidemia (MMA) in three, and carnitine-acylcarnitine translocase deficiency (CACTD) in one.